Menu Search
Equities

Cannabist Company Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VW5:DUS

Cannabist Company Holdings Inc

Actions
  • Price (EUR)0.0317
  • Today's Change0.001 / 2.59%
  • Shares traded25.00k
  • 1 Year change-50.10%
  • Beta1.0195
Data delayed at least 15 minutes, as of Feb 06 2026 18:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

The Cannabist Company Holdings Inc. is a cultivator, manufacturer and provider of cannabis products and related services, with licenses in 11 United States jurisdictions. The Company’s principal business activity is the production and sale of cannabis as regulated by the regulatory bodies and authorities of the jurisdictions in which it operates. The Company operates 69 facilities including 54 dispensaries and 15 cultivation and manufacturing facilities, including those under development. The Company is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. Its retail brand, Cannabist, creates a national dispensary network that leverages proprietary technology platforms. The Company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.

  • Revenue in CAD (TTM)479.63m
  • Net income in CAD-245.35m
  • Incorporated2019
  • Employees1.68k
  • Location
    Cannabist Company Holdings Inc321 Billerica Road, Suite 204CHELMSFORD 01824United StatesUSA
  • Phone+1 (212) 554-3424
  • Websitehttps://cannabistcompany.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.